Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2009
12/03/2009WO2007138334A3 Methods for identifying an agent that modulates type i or type ii pip kinase activity or expression
12/03/2009US20090300803 Gene coding for acetolactate synthase
12/03/2009US20090300796 Transgenic Plant-Based Methods for Plant Pests Using Rnai
12/03/2009US20090300794 Manipulation Of The Nitrogen Metabolism
12/03/2009US20090300788 Spinach line smb66-1082f
12/03/2009US20090300787 Spinach line smb66-1100m
12/03/2009US20090300786 Spinach line omb66-1101m
12/03/2009US20090300785 Spinach line ssb66-1083f
12/03/2009US20090300784 Corn event mir162
12/03/2009US20090300778 Neutral Sphingomyelinase-E and Its Use
12/03/2009US20090299763 Methods of cell-based technologies
12/03/2009US20090299650 Systems and methods for filtering target probe sets
12/03/2009US20090299640 Methods and Compositions Involving Intrinsic Genes
12/03/2009US20090299161 Marker of wound infection
12/03/2009US20090299130 Methods and compositions for improved fertilization and embryonic survial
12/03/2009US20090299061 Fluorescence assays with improved sensitivity
12/03/2009US20090298920 Chimeric transfer rna and use thereof for the production of rna by a cell
12/03/2009US20090298918 Alternative Splicing Isoform of Lox-I Protein Encoding Gene, and Uses Thereof
12/03/2009US20090298912 Arginase II: A Target treatment of aging heart and heart failure
12/03/2009US20090298910 Regulation of epigenetic control of gene expression
12/03/2009US20090298909 Multiple RNA Polymerase III Promoter Expression Constructs
12/03/2009US20090298880 Methods for the administration of iloperidone
12/03/2009US20090298873 Methods of reducing microbial resistance to drugs
12/03/2009US20090298842 Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor
12/03/2009US20090298839 Adrb2 gene polymorphism associated with intraocular pressure response to topical beta-blockers
12/03/2009US20090298838 Method for Determination of Effective Dose of Methotrexate
12/03/2009US20090298783 Cosmetic Compositions
12/03/2009US20090298775 Method of measuring neprilysin activity
12/03/2009US20090298771 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
12/03/2009US20090298766 Detection and treatment of cancers
12/03/2009US20090298764 Gene and pathway and their use in methods and compositions for predicting onset or progression of autoimmune and/or autoinflammatory diseases
12/03/2009US20090298763 Polynucleotides and polypeptide sequences involved in the process of bone remodeling
12/03/2009US20090298756 Functions and uses of gpr39 gene in mammalian central nervous system
12/03/2009US20090298717 Micro-particle array analysis system, micro-particle array kit, and chemical analysis method
12/03/2009US20090298711 Vasopressin pathway polymorphisms as indicators of subject outcome in critically ill subjects
12/03/2009US20090298709 Assays for determining telomere length and repeated sequence copy number
12/03/2009US20090298702 Nucleic acid sequencing using a compacted coding technique
12/03/2009US20090298701 Predictors of patient response to treatment with egf receptor inhibitors
12/03/2009US20090298195 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions
12/03/2009US20090298176 siRNA targeting KRAS
12/03/2009US20090298161 Surface Treatment
12/03/2009US20090298125 Halohydrin dehalogenases and related polynucleotides
12/03/2009US20090298116 Cell culture apparatus having different micro-well topography
12/03/2009US20090298115 Fluorescent Gold Nanocluster and Method for Forming the Same
12/03/2009US20090298114 Apparatus and methods for imaging and modification of biological samples
12/03/2009US20090298113 Ex vivo human skin model
12/03/2009US20090298112 Mouse model and treatment of hereditary inclusion body myopathy
12/03/2009US20090298111 Method and composition for a protein transduction technology and its applications
12/03/2009US20090298110 Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
12/03/2009US20090298109 Method for identifying bplp and opiorphin agonists or antagonists
12/03/2009US20090298108 Method for Identifying PDE11 Modulators
12/03/2009US20090298107 Methods for diagnosing chronic diarrhea through protein secretion analysis
12/03/2009US20090298106 Methods for Monitoring Immunosuppressant Drug Levels, Renal Function, and Hepatic Function Using Small Volume Samples
12/03/2009US20090298105 Reconstituted histone methyltransferase complex and methods of identifyi ng modulators thereof
12/03/2009US20090298104 Reference electrodes having an extended lifetime for use in long term amperometric sensors
12/03/2009US20090298103 Predicting hemostatic risk; dependence on plasma composition
12/03/2009US20090298102 Cell Potency Assay
12/03/2009US20090298093 Reagents for the Detection of Protein Phosphorylation in ATM & ATR Kinase Signaling Pathways
12/03/2009US20090298089 Novel method for detecting and analyzing protein interactions in vivo
12/03/2009US20090298087 Methods and probes for the detection of cancer
12/03/2009US20090298086 a polynucleotide comprising a nucleotide sequence or complement encoding a polypeptide comprising a farnesyltranstransferase beta subunit, used to improve tolerance to drought in mature plants
12/03/2009US20090298085 Using presence of bcl-2 gene translocation as evaluative tool in prognosing/diagnosing breast cancer
12/03/2009US20090298084 Gene and protein expression profiles associated with the therapeutic efficacy of irinotecan
12/03/2009US20090298083 Phospho-Specific Anti-Pax3 Antibodies
12/03/2009US20090298082 Biomarker panels for predicting prostate cancer outcomes
12/03/2009US20090298081 Methods of treatment utilizing binding proteins of the interleukin-21 receptor
12/03/2009US20090298080 METHODS AND REAGENTS FOR DETECTING CpG METHYLATION WITH A METHYL CpG BINDING PROTEIN (MBP)
12/03/2009US20090298079 High affinity binding site of hgfr and methods for identification of antagonists thereof
12/03/2009US20090298078 Method for the detection of an activation of the immune system or the extent of cell death
12/03/2009US20090298077 Assay for measurement of apurinic/apyrimidinic (ap) sites and for screening ap-site reactive compounds
12/03/2009US20090298076 Detection of salmonella by real-time multiplex pcr
12/03/2009US20090298075 Compositions and methods for nucleic acid sequencing
12/03/2009US20090298074 Modulators of ELOVL5 for treating acne or hyperseborrhea
12/03/2009US20090298073 Kidney Toxicity Biomarkers
12/03/2009US20090298072 DNA Sequencing by Nanopore Using Modified Nucleotides
12/03/2009US20090298071 Method for testing drug sensitivity in solid tumors by quantifying mrna expression in thinly-sliced tumor tissue
12/03/2009US20090298070 Method for analyzing metabolites flux using converging ratio determinant and split ratio determinant
12/03/2009US20090298069 Probe, probe set, probe-immobilized carrier, and genetic testing method
12/03/2009US20090298068 Method and test kit for the diagnosis and/or making predictions about and/or for the assessment of the efficacy of therapeutic agents for the treatment of ovarian cancer and method of planning a regimen for the treatment of ovarian cancer
12/03/2009US20090298067 Devices and methods for detecting cells and other analytes
12/03/2009US20090298066 Sex-Specific Marker for Shrimps and Prawns
12/03/2009US20090298065 Methods for Identifying Functional Noncoding Sequences
12/03/2009US20090298064 Genomic Sequencing
12/03/2009US20090298063 IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
12/03/2009US20090298062 Method for determination of the length of the g-tail sequence and kit for the method
12/03/2009US20090298061 Diagnostic Methods for the Prediction of Therapeutic Success, Recurrence Free and Overall Survival in Cancer Therapy
12/03/2009US20090298060 Methods for diagnosing and monitoring the status of systemic lupus erythematosus
12/03/2009US20090298059 System for the Integrated and Automated Analysis of DNA or Protein and Method for Operating Said Type of System
12/03/2009US20090298058 Inhibitors of PGHS-2Transactivator Activity
12/03/2009US20090298057 Primer and Probe for Use in Detection of Mycobacterium Kansasii and Method for Detection of Mycobacterium Kansasii Using the Same
12/03/2009US20090298056 Method of identifying cd4+ t cell antigens
12/03/2009US20090298055 Production of proteins
12/03/2009US20090298054 Epigenetic methods and nucleic acids for the detection of breast cell proliferative disorders
12/03/2009US20090298053 Use of novel biomarkers for detection of testicular carcinoma in situ and derived cancers in human samples
12/03/2009US20090298052 Diagnosing or Predicting the Course of Breast Cancer
12/03/2009US20090298051 Test Kit and Method for Detecting Bacteriophage
12/03/2009US20090298050 Immunochromatographic device
12/03/2009US20090298049 Methods for sample tracking
12/03/2009US20090298048 Non-fluorescent, non-enzymatic, chemiluminescent aqueous assay
12/03/2009US20090298047 Method for distinguishing between kidney dysfunctions